Value of Early Detection

​Men today are being diagnosed with prostate cancer only 27% of the time in Stage 1 of the cancer.  Unfortunately, treatment costs and the harmful effects of the treatments, including incontinence, impotence, and mortality, can rise dramatically with each stage of detection, while survivability rates reduce. Studies have shown that cancer patients are 5 times more likely to file for bankruptcy. 

​​

Prostac® is a straightforward molecular blood test that facilitates an early, precise prostate cancer detection, aiming to save men's lives, improve their quality of life, and protect them and their families' financially.